Ontario’s COVID-19 Genomics Rapid Response Coalition 

 

    About    

To accelerate the genomic characterization and surveillance of SARS-CoV-2 in Ontario and to help expedite patient genome sequencing through a coordinated approach bringing together all of the province’s genomics resources and capacity to enable timely and comprehensive genomic analysis.

Genomics

Infrastructure

Standardized Sequencing Methodologies

Bioinformatics

Infrastructure

Data Management & Sharing

The ON-CoV Coalition is designed to provide for method standardization and coordination of:

1

Collecting Patient Samples and Metadata

2

Sequencing

3

Data Curation and Management

4

Epidemiological Studies 

This work will expedite real-time testing and reporting to inform public health and public policy, help manage and overcome the ongoing COVID-19 crisis and ensure scalability for Ontario’s future pandemics preparedness.

Why Genomics?

Genomic technologies are the foundation for the solutions necessary to combat the ongoing COVID-19

pandemic. Ontario’s world-leading expertise in genomics, bioinformatics, genomics epidemiology, and artificial intelligence, can expedite Ontario’s response to COVID-19. 

The results reported by the Coalition will inform vaccine and therapeutic development.

Why Ontario Genomics?

Over the past 20 years, Ontario Genomics, together with the Ontario Government, Genome Canada, and academic, clinical and industry partners, has built a world-leading genomics ecosystem in Ontario with over $2.7B in funding leveraged for research, translation and the establishment of genomic technology platforms. 

Ontario Genomics is well-positioned to provide and promote:
COLLABORATION
LEADERSHIP
EXPERTISE
 

    Members    

ONCoV Genomics Coalition Members

Aaron Campigotto

University of Toronto

Bettina Hamelin

Ontario Genomics

Samira Mubareka

Sunnybrook Health Sciences / University of Toronto

Danielle Brabant-Kirwan

Health Sciences North

Robyn Lee

Dalla Lana School of Public Health, University of Toronto

Letitia Nadalin Penno

Canadore College

Nahuel Fittipaldi

Public Health Ontario

Andrew G. McArthur

McMaster University

Marc Fiume

DNAstack

Allison McGeer

Sinai Health Systems

Stephen Scherer

Hospital for Sick Children / University of Toronto

TCAG / CGEn

Prameet M. Sheth

Kingston Health Sciences Centre / Queen’s University

Jared Simpson

Ontario Institute for Cancer Research

Michael Szego

Unity Health Toronto / University of Toronto

David Villeneuve

Canadore College

Bo Wang

Peter Munk Cardiac Centre, UHN / University of Toronto

W-SWootton.jpg

Sarah Wootton

University of Guelph

 

We are proactively working with the research community, partner genome centres, and governments to accelerate the genomic characterization and surveillance of SARS-CoV-2 in Ontario. Learn more and stay up-to-date about our COVID-19 programs and important resources.

 

    Partners    

 

    Contact    

 

A closer look at Canada's homegrown COVID-19 vaccine candidates

Scientists across Canada are using a range of technologies, from more traditional protein subunit vaccines to newer technologies such as replicating viral vector and DNA vaccines to produce immunity against SARS-CoV-2.

McMaster researchers awarded $1.475M to further investigate COVID-19

A team of McMaster researchers has been awarded $1.475M from the federal government to further investigate COVID-19. Overall, the fund will provide close to $28M for 79 projects at 52 universities, research hospitals, colleges, polytechnics and Cégeps across Canada

Consortium Secures $5M to Expand Genomics Platform for COVID Research

A national consortium led by DNAstack will expand development of a software platform for genomics and health data and apply it to COVID-19. The $5.1M project, called COVID Cloud, is co-funded by Canada’s Digital Technology Supercluster and aims to increase Canada’s capacity to harness exponentially growing volumes of genomics and biomedical data to advance precision health.

December 1, 2020

November 6, 2020

October 19, 2020

© 2020 by Ontario Genomics